Market Tracker

01/24 12:12pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of 11:56am ET
 -0.3589 / -0.94%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

What Lies Ahead for Pharma ETFs?
Jan 19 / - Paid Partner Content
Trump's First Press Conference Puts These ETFs in Focus
Jan 12 / - Paid Partner Content


1 month-4.94% 3 years-2.57%
3 months-9.78% 5 years+11.41%
1 year-16.15% Since inception+11.18%
Data through 01/24/2017

Quote Details

Previous close$38.05
Open day’s range37.48 – 38.16
Net asset value (NAV)38.06 (01/23/2017)
Daily volume82,974
Average volume (3 months)265,545
Data as of 11:56am ET, 01/24/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+11.41%+16.84%
Expense Gross exp ratio0.35%1.32%
Risk 5 year sharpe ratio0.671.08
Net assets$467.0M$2.8B
Average market cap$8.7B$32.0B
Average P/E20.019.5
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AGN Allergan4.86%
HZNP Horizon Pharma PLC4.85%
LLY Eli Lilly and Co4.82%
JAZZ Jazz Pharmaceuticals PLC4.74%
ENDP Endo International PLC4.68%
MYL Mylan NV4.65%
ZTS Zoetis Inc4.59%
JNJ Johnson & Johnson4.56%
PFE Pfizer4.56%
BMY Bristol-Myers Squibb4.56%